These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16762540

  • 21. [Optimizing plasma cell content in bone marrow aspirates].
    Hoffmann T, Favre G, Gratwohl A, Passweg J, Mathys S, Borel J, Speck B, Tichelli A.
    Schweiz Med Wochenschr; 1998 Oct 17; 128(42):1611-3. PubMed ID: 9824893
    [Abstract] [Full Text] [Related]

  • 22. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.
    Paiva B, Almeida J, Pérez-Andrés M, Mateo G, López A, Rasillo A, Vídriales MB, López-Berges MC, Miguel JF, Orfao A.
    Cytometry B Clin Cytom; 2010 Jul 17; 78(4):239-52. PubMed ID: 20155853
    [Abstract] [Full Text] [Related]

  • 23. [Multiple myeloma immunophenotyping: method validation].
    Vergnolle I, Rieu JB, Avet-Loiseau H, Corre J, Vergez F.
    Ann Biol Clin (Paris); 2019 Apr 01; 77(2):197-217. PubMed ID: 30998199
    [Abstract] [Full Text] [Related]

  • 24. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
    Galani Z, Viniou N, Kyrtsonis MC, Sachanas S, Antoniou T, Dimopoulou MN, Vassilakopoulos TP, Korkolopoulou P, Nakopoulou L, Patsouris E, Pangalis GA.
    Anticancer Res; 2007 Apr 01; 27(1B):571-4. PubMed ID: 17348443
    [Abstract] [Full Text] [Related]

  • 25. [Options for histological examination of bone marrow during diagnosis of multiple myeloma].
    Fabian P, Moulis M.
    Vnitr Lek; 2006 Nov 01; 52 Suppl 2():66-70. PubMed ID: 18175431
    [Abstract] [Full Text] [Related]

  • 26. [Immunoglobulin heavy chain gene rearrangements in the monoclonal gammopathies].
    Bosaleh A, Denninghoff V, Garcia A, Rescia C, Avagnina A, Elsner B.
    Medicina (B Aires); 2005 Nov 01; 65(3):219-25. PubMed ID: 16042132
    [Abstract] [Full Text] [Related]

  • 27. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
    Nadav L, Katz BZ, Baron S, Yossipov L, Polliack A, Deutsch V, Geiger B, Naparstek E.
    Br J Haematol; 2006 Jun 01; 133(5):530-2. PubMed ID: 16681641
    [Abstract] [Full Text] [Related]

  • 28. [Non-excretory plasma cell myeloma (apropos of 2 new cases)].
    Menkes CJ, Herreman G, Preud'homme JL, Godeau P, Delbarre F.
    Nouv Presse Med; 1972 Jan 29; 1(5):309-12. PubMed ID: 4551593
    [No Abstract] [Full Text] [Related]

  • 29. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
    Joshi R, Horncastle D, Elderfield K, Lampert I, Rahemtulla A, Naresh KN.
    J Clin Pathol; 2008 Feb 29; 61(2):213-6. PubMed ID: 17526802
    [Abstract] [Full Text] [Related]

  • 30. Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.
    Millá F, Oriol A, Aguilar J, Aventín A, Ayats R, Alonso E, Domingo A, Feliu E, Florensa L, López A, Pérez-Vila E, Rozman M, Sánchez C, Vallespí T, Woessner S.
    Am J Clin Pathol; 2001 Jan 29; 115(1):127-35. PubMed ID: 11190798
    [Abstract] [Full Text] [Related]

  • 31. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G, Pirali F, Inzoli MR.
    Minerva Med; 1981 Sep 29; 72(37):2479-83. PubMed ID: 7279268
    [Abstract] [Full Text] [Related]

  • 32. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S.
    Haematologica; 2006 Jul 29; 91(7):972-5. PubMed ID: 16818287
    [Abstract] [Full Text] [Related]

  • 33. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B, Tafuri C, Perini M, Rota G, Peretti P.
    Quad Sclavo Diagn; 1984 Jun 29; 20(2):149-54. PubMed ID: 6528014
    [Abstract] [Full Text] [Related]

  • 34. Immunophenotyping of plasma cells in multiple myeloma.
    Mateo Manzanera G, San Miguel Izquierdo JF, Orfao de Matos A.
    Methods Mol Med; 2005 Jun 29; 113():5-24. PubMed ID: 15968091
    [Abstract] [Full Text] [Related]

  • 35. [First manifestation of multiple myeloma as lethal streptococcal sepsis].
    Austein T, Kerstan H, Aue G, Schnieder I, von Bloh J, Badge S.
    Med Klin (Munich); 2006 Nov 15; 101(11):905-7. PubMed ID: 17235478
    [Abstract] [Full Text] [Related]

  • 36. Minimal residual disease monitoring in multiple myeloma.
    Davies FE, Rawstron AC, Owen RG, Morgan GJ.
    Best Pract Res Clin Haematol; 2002 Mar 15; 15(1):197-222. PubMed ID: 11987924
    [Abstract] [Full Text] [Related]

  • 37. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
    Atanackovic D, Luetkens T, Hildebrandt Y, Arfsten J, Bartels K, Horn C, Stahl T, Cao Y, Zander AR, Bokemeyer C, Kröger N.
    Clin Cancer Res; 2009 Feb 15; 15(4):1343-52. PubMed ID: 19190130
    [Abstract] [Full Text] [Related]

  • 38. [How to diagnose a patient precisely as a myeloma patient?--Lots of problems during diagnostic process].
    Miwa A.
    Nihon Rinsho; 2007 Dec 15; 65(12):2268-79. PubMed ID: 18069272
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.